 patients with severe asymptomatic carotid artery stenosis. The ACAS, which randomized 1662 patients to immediate CEA vs medical therapy
demonstrated the superiority of CEA over antiplatelet
therapy alone for asymptomatic patients with carotid stenosis of >60% (5.1% for surgical patients and 11.0% for patients treated medically; aggregate risk reduction, 53%;
95% conﬁdence